Abstract
With the availability of new, broad-spectrum antibiotics, initial therapy with a single agent has become an alternative to classic combinations in the management of febrile, neutropenic cancer patients. The aims of this study were to compare the efficacy of ceftazidime and imipenem as empirical monotherapy of febrile episodes in neutropenic patients, and to examine the frequency with which second-line antibiotics (amikacin, vancomycin, or both) were required. A prospective clinical trial was carried out in a single centre. Eligible patients with solid tumours or lymphoma were randomised to receive monotherapy with ceftazidime or imipenem. In the event of no response, amikacin and/or vancomycin were added in 48-72 h intervals (sequentially, or according to clinical or microbiological data). Efficacy was evaluable for 111 assessable episodes. Median neutrophil count at entry was 100 cells/microliters and median duration of neutropenia was 4 days. Febrile episodes were classified as microbiologically (34%) or clinically documented (42%), and fever of unknown origin (24%). Gram-negative infections (57%) predominated over gram-positive isolates (30%). The overall success rate with monotherapy (69% versus 70%), or with modification (...Continue Reading
References
Jan 1, 1978·The Journal of Infectious Diseases·S C SchimpffS H Zinner
Nov 1, 1991·The Journal of Infectious Diseases·J W SandersR D Moore
Dec 1, 1991·Annals of Internal Medicine·D J WinstonR E Champlin
Jul 1, 1990·Antimicrobial Agents and Chemotherapy·R LiangD Todd
Jan 1, 1990·Pediatric Hematology and Oncology·C HauerH Lackner
Nov 1, 1989·Reviews of Infectious Diseases·J C Wade
Dec 31, 1987·The New England Journal of Medicine·UNKNOWN EORTC International Antimicrobial Therapy Cooperative GroupS H Zinner
Dec 1, 1988·Archives of Internal Medicine·J A TalcottL Goldman
Jan 1, 1988·European Journal of Cancer & Clinical Oncology·J KlasterskyC Viscoli
Aug 28, 1986·The New England Journal of Medicine·P A PizzoJ McKnight
Jun 7, 1985·The American Journal of Medicine·J C WadeS C Schimpff
Jul 1, 1983·The Journal of Antimicrobial Chemotherapy·B E de PauwT Bothof
Jul 1, 1983·The Journal of Antimicrobial Chemotherapy·V FainsteinM Valdivieso
Dec 1, 1984·Antimicrobial Agents and Chemotherapy·M PiccartD Weerts
Jun 1, 1993·The Journal of Antimicrobial Chemotherapy·S R NorrbyM Glauser
May 6, 1993·The New England Journal of Medicine·P A Pizzo
Citations
May 3, 2003·International Journal of Antimicrobial Agents·Jean A Klastersky
Sep 5, 2001·The Journal of Infection·I MalikH Yousuf
Oct 21, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Robert W FinbergMichael J Rybak
Feb 23, 1999·Infection·E S DietrichF D Daschner
Mar 19, 2011·Pediatric Hematology and Oncology·Hacı Ahmet DemirMünevver Büyükpamukçu
May 29, 2003·Leukemia & Lymphoma·E JourdanA Sotto
Apr 1, 2011·Pharmacotherapy·April D MillerCharles L Bennett
Apr 30, 1999·Mayo Clinic Proceedings·W C Hellinger, N S Brewer
Apr 20, 2014·The Journal of Antimicrobial Chemotherapy·Joan P CannonShellee A Grim
Dec 14, 2005·The Journal of Antimicrobial Chemotherapy·Mical PaulLeonard Leibovici
Nov 12, 2010·The Cochrane Database of Systematic Reviews·Mical PaulLeonard Leibovici
May 24, 2020·Medicine·Katerina ToriEleftherios Mylonakis
Jun 3, 2021·Antibiotics·Diaa AlrahmanyIslam M Ghazi